Showing results (1701-1710 of 2,324) with videos related to
Sort By:
Pageof 233
Expert Opinion on Therapeutic Targets|August 23, 2024
VPS35 or retromer as a potential target for neurodegenerative disorders: barriers to progressAnika Wu, Daehoon Lee, Wen-Cheng XiongExpert Opinion on Therapeutic Targets|October 29, 2024
Potential molecular targets for the pharmacologic management of non-traumatic osteonecrosisEdward Y Cheng, Alireza MirzaeiExpert Opinion on Therapeutic Targets|November 11, 2024
ULK1 as a therapeutic target in kidney diseases: Current perspectiveShruti Shreya, Neha Dagar, Vishwadeep Shelke, et al.Expert Opinion on Therapeutic Targets|June 29, 2024
Epigenetic regulation of immune cells in systemic lupus erythematosus: insight from chromatin accessibilityZhao-Xing Gao, Tian He, Peng Zhang, et al.Expert Opinion on Therapeutic Targets|June 28, 2024
Pathways and targeting avenues of BRAF in non-small cell lung cancerEvgeny N Imyanitov, Natalia V Mitiushkina, Ekatherina Sh Kuligina, et al.Expert Opinion on Therapeutic Targets|October 28, 2023
Can we suppress chronic systemic inflammation and postpone age-related diseases by targeting the IgG glycome?GordAn LaucExpert Opinion on Therapeutic Targets|September 15, 2023
The neuroinflammatory astrocytic P2X7 receptor: Alzheimer's disease, ischemic brain injury, and epileptic stateYoung Ha Ahn, Yong Tang, Peter IllesExpert Opinion on Therapeutic Targets|September 14, 2023
Fatty acid-mediated signaling as a target for developing type 1 diabetes therapiesIvo Díaz Ludovico, Soumyadeep Sarkar, Emily Elliott, et al.Expert Opinion on Therapeutic Targets|August 31, 2023
New drug targets for the treatment of gout arthritis: what's new?Tiago H Zaninelli, Geovana Martelossi-Cebinelli, Telma Saraiva-Santos, et al.Expert Opinion on Therapeutic Targets|September 5, 2023
Are tumour-associated carbonic anhydrases genuine therapeutic targets for photodynamic therapy?Amina Merabti, Sébastien Richeter, Claudiu T Supuran, et al.Pageof 233